Results

Total Results: 1,495 records

Showing results for "harms".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
    July 28, 2010 - populations were studied, the detailed components of the treatment program, and the health outcomes and harms … What are the potential safety issues and harms that may be associated with an MPP? … Potential Safety Issues or Harms E. … Potential Safety Issues or Harms Study Safety Issues or Harms Assessed MPP Therapy Comparison
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - Key Question Key Question: What are the comparative benefits and harms of different contrast media in … How do benefits or harms of contrast media differ by patient characteristics (known risk factors such … How do benefits or harms differ by the dose of contrast medium (i.e., by volume of dose and number … How do benefits or harms of contrast media differ according to the type of preventive strategy used? … We did not find any studies that examined whether the benefits or harms of contrast media differed
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
    May 24, 2010 - What are the harms associated with prevention strategies? c. … Question 3: What is the comparative effectiveness and harms of different antibiotic treatments? a. … Question 4: What are the effectiveness and harms of non-antibiotic adjunctive interventions? a. … environmental cultures  Days to resolution of diarrhea (choice of faster working treatment) Harms … Treatment of false positives Increased resistance Isolation harms Prevention Patient Specific
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - resulted in contradictory conclusions and recommendations regarding the comparative effectiveness and harms … determined that increasing comprehensiveness by reviewing all possible observational studies that present harms … the strength of the body of evidence to answer KQs on the comparative effectiveness, efficacy, and harms
  5. effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
    April 01, 2016 - Harms due to overtreatment or undertreatment e. Survival f. Quality of life KQ 3. … the choice of test (or test strategy) might influence choice of treatment, timeliness of treatment, harms … • For comparative harms of over- or undertreatment (part of KQ2), this means reporting the percentage
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cultural-competence_research-protocol.pdf
    July 09, 2014 - Comparative effectiveness reviews evaluate the evidence for both benefits and harms, or adverse effects … In the case of cultural competence interventions, harms may include unintended consequences of an intervention … Studies specifically addressing treatment harms may also include retrospective and case series designs
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-reviews-end-user_white-paper.pdf
    April 01, 2016 - questions address what the end-user needs, including clinical outcomes and consideration of benefits and harms … guideline developer) felt that the rapid review was limited in terms of the spectrum of benefits and harms … "  KIs commented on the fact that there is generally more than the evidence of benefits and harms
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol-amendment.pdf
    January 08, 2025 - event data were collected actively (e.g., all participants were asked about the occurrence of specific harms … Quality Assessment Scale for adverse events: Delphi Consensus on important criteria for evaluating harms … AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol.pdf
    June 10, 2024 - event data were collected actively (e.g., all participants were asked about the occurrence of specific harms … Quality Assessment Scale for adverse events: Delphi Consensus on important criteria for evaluating harms … AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
    April 01, 2013 - interventions yield small to moderate effects, and the benefits must be weighed against the potential harms … Because only limited data on harms were reported in the trials examined, data from non-SMI populations … Quasi-experimental or clinical records-based observational studies Limited evidence about the benefits and harms
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_research-protocol.pdf
    December 09, 2013 - Were harms or adverse effects collected in the studies; what were they? f. … What comparators were used to examine benefits and harms? 4. … different populations (possibly by study design) Decision Clinical Inclusion Exclusion Sample Comparator Harms … (ethical/ Aid/Use population/ criteria- criteria size/Study emotional design harms) General Table
  12. effectivehealthcare.ahrq.gov/products/collections/making-healthcare-safer-IV
  13. effectivehealthcare.ahrq.gov/products/insomnia/research
  14. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - Few studies on harms lasted longer than 2 years. … The FDA approval process focuses on short- term harms, providing less incentive for pharmaceutical companies
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-centered-medical-home_research-protocol.pdf
    February 23, 2012 - unintended consequences (e.g., decrease in levels of indicated care for non-priority conditions) or other harms … In addition, the association of PCMH with unintended consequences or other harms is demonstrated.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
    December 01, 2011 - For harms we also included large uncontrolled studies. … Some sections are synthesized well (KQ1 and also harms), while others are not quite there yet (KQ 2
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
    June 06, 2011 - However, it is not clear whether the diagnostic accuracy or the relative balance of benefits and harms … studies addressing prognostic/risk stratification, predictors of accuracy, cardiovascular outcomes, and harms
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
    September 14, 2016 - Immunoglobulin E (IgE) § Allergen-specific Immunoglobulin G4 (IgG4) Outcomes for Key Questions 2 and 4 o Harms … For key questions 2 and 4 we will grade harms: anaphylaxis, hypersensitivity adverse effects and death
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/advanced-care-decision-aids_disposition-comments.pdf
    July 29, 2014 - Peer Reviewer #4 Findings Study Designs: When discussing potential harms of decision aids, the authors … We have changed the language in that section and added the need to consider how harms should be conceptualized
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_disposition-comments.pdf
    March 01, 2012 - Peer Reviewer #3 Abstract I tend to see things a bit differently: benefits do not outweigh harms in

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: